Published on: LinkedIn (Spencer Knight) The FDA has approved Novartis’ Leqvio (inclisiran) as the first siRNA drug to lower LDL-C without...

Published on: ScienceAlert For the first time, a type 1 diabetes patient has begun producing insulin after receiving gene-edited islet...

Published on: LinkedIn (Spencer Knight) In just five days, two breakthrough approvals have reshaped treatment for metabolic...

Published on: LinkedIn (Spencer Knight) The CGT field saw a breakthrough weekend with multiple milestones. Precigen secured FDA approval...

Published on: Autolus Therapeutics The European Commission has granted marketing authorization for AUCATZYL (obecabtagene autoleucel) to...

Published on: Precigen Investors The U.S. FDA has granted full approval to PAPZIMEOS (zopapogene imadenovec-drba), the first therapy for...

Published on: Alliance for Regenerative Medicine The Alliance for Regenerative Medicine’s Q2 2025 Sector Snapshot showcases pivotal...

Published on: Cytotherapy CAR T-cell therapy has transformed outcomes for aggressive B-cell Non-Hodgkin lymphoma, yet many eligible...

Published on: Forbes A clinical trial by Vertex Pharmaceuticals has shown that lab-grown stem cell–derived islet cells can restore...

Published on: Multiple Sclerosis News Today A U.S. trial has treated the first multiple sclerosis (MS) patient with azercabtagene...

Published on: LinkedIn (Spencer Knight) A groundbreaking case in glioblastoma treatment has emerged from a U.S. clinical trial. Pamela...

Published on LinkedIn via Spencer Knight The FDA has given accelerated approval to Jazz Pharmaceuticals’ Modeyso (dordaviprone) for...

Published by UMC Utrecht In the PASSIoN safety study at UMC Utrecht, ten newborns with perinatal stroke received a single dose of...

Published in The Japan Times Sumitomo Pharma has applied for regulatory approval in Japan to market a cell therapy that transplants...

Published in Regenerative Therapy (Vol. 30, Dec 2025) A study in Regenerative Therapy shows that adipose-derived stem cells (ADSCs)...

Published on LinkedIn via Spencer Knight Jan Janisch-Hanzlik, 49, became the first person in the world to receive allogeneic CAR‑T...

Published on LinkedIn via Spencer Knight SERB Pharmaceuticals will acquire Y-mAbs Therapeutics for $412 million, marking a strategic...

Published on OncoDaily via Hung Trinh In a first‑in‑human trial led by UCLA, researchers demonstrated that hematopoietic stem cells...

Published by Cytotherapy via LinkedIn A new paper describes a fully integrated platform that automates three core CAR‑T manufacturing...

Published on LinkedIn via Spencer Knight In a groundbreaking study by Karolinska Institutet, ten patients born deaf due to a mutation in...